A Comprehensive Review of the Main Lignan Components of Schisandra Chinensis (North Wu Wei Zi) and Schisandra Sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein...

Overview

Journal Front Pharmacol

Date 2022 Apr 1

PMID 35359848

Authors

Feng Zhang

Jianxiu Zhai

Nan Weng

Jie Gao

Jun Yin

Wansheng Chen

Affiliations

Soon will be listed here.

Abstract

Wu Wei Zi is the dried fruit of (Turcz.) Baill. or Rehd. et Wils. (family Magnoliaceae). As a homology of medicine and food, it has been widely used in China for thousands of years, to tonify the kidney, and ameliorate neurological, cardiovascular, liver, and gastrointestinal disorders. As its increasing health benefits and pharmacological value, many literatures have reported that the combination of Wu Wei Zi in patients has led to fluctuations in the blood level of the combined drug. Therefore, it is extremely important to evaluate its safety concern such as drug-drug interactions (DDIs) when patients are under the poly-therapeutic conditions. This review summarized the effects of Wu Wei Zi extract and its major lignan components on cytochrome P450 and P-glycoprotein activities, the change of which could induce metabolic DDIs. Our review also elaborated on the differences of the major lignan components of the two species, as well as the absorption, distribution, metabolism, and elimination of the major lignans. In conclusion, these results would enhance our understanding of the DDI mechanisms involving Wu Wei Zi, and may potentially untangle some differing and conflicting results in the future.

Citing Articles

Electrochemical Fingerprint Analyses Using Voltammetry and Liquid Chromatography Coupled with Multivariate Analyses for the Discrimination of Schisandra Fruits.

Machida K, Kotani A, Osaki T, Kobayashi A, Yamamoto K, Hakamata H Molecules. 2025; 30(1.

PMID: 39795106 PMC: 11721992. DOI: 10.3390/molecules30010048.

Transcriptome-wide analysis of PIP reductase gene family identified a phenylpropene synthase crucial for the biosynthesis of dibenzocyclooctadiene lignans in .

Qiang T, Chen Y, Li B, Dong Y, Wei X, Liu J Synth Syst Biotechnol. 2024; 9(1):78-87.

PMID: 38283950 PMC: 10819558. DOI: 10.1016/j.synbio.2023.11.011.

Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs.

Siwek M, Woron J, Wrzosek A, Gupalo J, Chrobak A Front Pharmacol. 2023; 14:1271776.

PMID: 37829299 PMC: 10565488. DOI: 10.3389/fphar.2023.1271776.

Extraction Techniques and Analytical Methods for Isolation and Characterization of Lignans.

Patyra A, Koltun-Jasion M, Jakubiak O, Kiss A Plants (Basel). 2022; 11(17).

PMID: 36079704 PMC: 9460740. DOI: 10.3390/plants11172323.

References

Jiang W, Wang X, Xu X, Kong L . Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Ther. 2010; 48(3):224-9. DOI: 10.5414/cpp48224. View

Fong W, Wan C, Zhu G, Chattopadhyay A, Dey S, Zhao Z . Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes. Planta Med. 2007; 73(3):212-20. DOI: 10.1055/s-2007-967120. View

Harding M, Galat A, Uehling D, Schreiber S . A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989; 341(6244):758-60. DOI: 10.1038/341758a0. View

Qin X, Bi H, Wang X, Li J, Wang Y, Xue X . Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506). Int J Pharm. 2010; 389(1-2):114-21. DOI: 10.1016/j.ijpharm.2010.01.025. View

Fan L, Mao X, Tao G, Wang G, Jiang F, Chen Y . Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica. 2009; 39(3):249-54. DOI: 10.1080/00498250802687657. View

Lai Q, Wei J, Mahmoodurrahman M, Zhang C, Quan S, Li T . Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime. Drug Des Devel Ther. 2015; 9:4997-5018. PMC: 4560515. DOI: 10.2147/DDDT.S89876. View

Zhou S, Feng X, Kestell P, Paxton J, Baguley B, Chan E . Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells. Eur J Pharm Sci. 2005; 24(5):513-24. DOI: 10.1016/j.ejps.2005.01.006. View

Li W, Xin H, Su M . Inhibitory effects of continuous ingestion of Schisandrin A on CYP3A in the rat. Basic Clin Pharmacol Toxicol. 2011; 110(2):187-92. DOI: 10.1111/j.1742-7843.2011.00787.x. View

Zhai J, Zhang F, Gao S, Chen L, Feng G, Yin J . Time- and NADPH-Dependent Inhibition on CYP3A by Gomisin A and the Pharmacokinetic Interactions between Gomisin A and Cyclophosphamide in Rats. Molecules. 2017; 22(8). PMC: 6152024. DOI: 10.3390/molecules22081298. View

10.

Liu K, Song Y, Liu Y, Peng M, Li H, Li X . An integrated strategy using UPLC-QTOF-MS and UPLC-QTOF-MRM (enhanced target) for pharmacokinetics study of wine processed Schisandra Chinensis fructus in rats. J Pharm Biomed Anal. 2017; 139:165-178. DOI: 10.1016/j.jpba.2017.02.043. View

11.

Qin X, Bi H, Wang C, Li J, Wang X, Liu L . Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method. Biomed Chromatogr. 2009; 24(4):399-405. DOI: 10.1002/bmc.1305. View

12.

Yang J, Duan J, Li G, Zhu Z, Zhu T, Qian D . [Determination of lignans in schisandrae sphenantherae fructus from different regions]. Zhongguo Zhong Yao Za Zhi. 2015; 39(23):4647-52. View

13.

Manikandan P, Nagini S . Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr Drug Targets. 2017; 19(1):38-54. DOI: 10.2174/1389450118666170125144557. View

14.

Zhang W, Zhu Y, Zhang Q, Ma L, Yang L, Guo W . [Research progress in application and mechanism of Schisandrae Chinensis Fructus for prevention and treatment of liver diseases]. Zhongguo Zhong Yao Za Zhi. 2020; 45(16):3759-3769. DOI: 10.19540/j.cnki.cjcmm.20200513.601. View

15.

Jin J, Bi H, Hu J, Zhong G, Zhao L, Huang Z . Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Biopharm Drug Dispos. 2010; 31(4):264-8. DOI: 10.1002/bdd.705. View

16.

Guo W, Shao Q, Zhang Y, Fan X . [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012; 41(1):6-12. DOI: 10.3785/j.issn.1008-9292.2012.01.002. View

17.

Wang B, Hu J, Sheng L, Li Y . [Effects of Schisandra chinensis (Wuweizi) constituents on the activity of hepatic microsomal CYP450 isozymes in rats detected by using a cocktail probe substrates method]. Yao Xue Xue Bao. 2011; 46(8):922-7. View

18.

Li L, Pan Q, Sun M, Lu Q, Hu X . Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1. Life Sci. 2006; 80(8):741-8. DOI: 10.1016/j.lfs.2006.11.002. View

19.

Ali M, Khan T, Fatima K, Ali Q, Ovais M, Khalil A . Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytother Res. 2017; 32(2):199-215. PMC: 7167792. DOI: 10.1002/ptr.5957. View

20.

Sowndhararajan K, Deepa P, Kim M, Park S, Kim S . An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed Pharmacother. 2017; 97:958-968. DOI: 10.1016/j.biopha.2017.10.145. View